CD146 glycoprotein belonging to cell adhesion molecules is considered to be a novel target on endothelial cell involved in tumor angiogenesis. The biosensor based on imaging ellipsometry (BIE) which is performed in null and off-null mode is used for CD146 detection as a trial by the following steps. Firstly, anti-CD146 antibody as ligand is immobilized on Protein G modified silicon substrate. Then, CD146 test is carried out and its calibration curve is established for the requirement of quantitative detection. Finally, 18 serum samples are detected quantitatively and their results are validated by ELISA's. The sensitivity for CD146 detection achieves the order of ng/ml and the relationship between BIE signal y (grayscale value) and CD146 concentration x (ng/ml) is y=3.3ln(x) +91.3. Compared with ELISA's, the majority of results are in agreement, and the results of two approaches have significant statistic relevance.
INTRODUCTION
As cancer becomes one of the most severe dangers for human beings [1] , a lot more attention has been paid to the field of cancers detection. So far, it has been proved that detection of tumor markers is an efficient method to make a prompt and early-stage diagnosis [2] . Therefore, the need for novel and effective methods which can detect tumor markers rapidly, sensitively and reliably is consequently being subjected to extensive interest.
The concept of biosensor based on imaging ellipsometry for visualization of biomolecular interactions was reported in 1995 [3, 4] . Imaging ellipsometry with the advantages of ellipsometry and microscopy simultaneously could measure the surface concentration of protein adsorbing layer accurately without any labeling. It provides possibility to apply BIE's function in a broad range of various biological systems, especially for the detection of protein interactions [5, 6] . So far, several bio-targets, such as five markers of Hepatitis B [7] , Phage M13KO7 [8] , and SARS Virus [9] , have been successfully tested with the biosensor.
CD146 is a member of cell adhesion molecule (CAMs) [10, 11] . In pathology, it is originally identified as a biomarker for melanoma detection [12] . A former study indicates that CD146 may play an important role in promoting melanoma progression. Enforced expression of CD146 on melanoma cells increases tumor growth, and decreasing CD146 expression releases tumor formation [13] . Nowadays, CD146 is considered as a novel target on endothelial cell involved in tumor angiogenesis [10] . In this investigation, CD146 is chosen to be a model of tumor markers and then tried to detect quantitatively with BIE.
MATERIALS AND METHODS

BIE and its detection principle
To perform molecular interaction as the high throughput immunoassays, BIE has been developed in our laboratory [5, 6, 14] . Now, it is mainly composed of a micro-fluidic reactor array system and an imaging ellipsometry reader.
A micro-fluidic reactor array system including 48 independent flow channels is used to fabricate protein microarray for high throughput detection by a series of continuous processes, including surface patterning, solution delivery, ligand immobilization, blocking, target capture, rinsing, etc [5, 6] . The micro-fluidic array system is composed of four main parts: sample reservoir, multi-cell array, multi-channels and pumps. When a silicon wafer substrate is placed on the multi-cell array to form closed paths, a patterned microarray can be fabricated because each cell has an independent inlet and outlet for solution delivery. The inlet microchannels are connected to the sample reservoir and the outlet micro-channels are connected with pumps offering negative pressure. Using the micro-fluidic reactor system, various ligands are delivered to different cells to form a sensing array, and each sensing surface can be prepared homogeneously.
Imaging ellipsometry acts as the data acquisition of the microarray. Imaging ellipsometry which combines the power of ellipsometry with microscopy and works in the off-null mode [3, 4] is an enhancement of standard single-beam ellipsometry. Upon the high sensitivity requirement for weak affinity biomolecular interactions, its sensitivity has been improved by the polarization setting optimization, the wavelength optimization and an imaging device with low noise. It can be utilized for the visualization of ultra-thin films and slight surface concentration change. Here, it is used to quantify the thickness distribution of protein layers [6, 15] . A slight variation of thickness can be remarkably distinguished by imaging ellipsometry and the result is represented by images in grayscale format (8 bits, 0-117 255 grayscale or 10 bits, 1024 grayscale). The grayscale value is approximately linearly proportional to the thickness corresponding to the surface concentration [15] .
Chemicals, samples and substrates
Silicon wafers are purchased from Beijing GRINM semiconductor Materials Company. 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC), succinic anhydride and aminopropyltriethoxysilane (APTES) are purchased from Acros Organics. N-Hydroxy-succinimide (NHS), blocking buffer, PBST buffer (PBS containing 0.05% Tween-20), Protein G and bovine serum albumin (BSA) are purchased from Sigma-Aldrich. Deionized water is produced by ion exchange demineralization, followed by passing through a Milli-Q plus system from Millipore. Mouse monoclonal antibody to CD146 and all human serum samples are kindly provided by Professor Yan's Group in the institute of Biophysics of Chinese Academy of Sciences.
Silicon wafer preparation and surface modification
Silicon wafer is used as solid surface for imaging ellipsometry biosensor. Due to the need of 48 throughputs, the silicon slides are cut into 25×13 mm 2 rectangular pieces. Then, aiming at washing out the organic and inorganic pollution, silicon wafers are cleaned with a mixture of 30% H 2 O 2 and concentrated H 2 SO4 (1:3 v/v) for 30 minutes. After being thoroughly rinsing with deionized water and pure ethanol, these silicon wafers are treated with an ethanol solution of APTES (5% APTES and 95% pure ethanol) and incubated 2 hours at room temperature [16] . Following by intensively rinsing in pure ethanol, the silicon wafers silanized with APTES are reacted with over-saturated succinic anhydride in ethanol for at least 3 hours [17] . After being rinsed with pure ethanol, the silicon wafers are stored in pure ethanol for ligands immobilization.
Detection of CD146
After surface modification, silicon wafer is placed into the micro-fluidic reactor system to immobilize anti-CD146 antibody. Because the anti-CD146 antibody is in ascites, it could not be assembled directly on the surface just depending on covalent immobilization. Therefore, protein G which is a common used method in protein purification is tried to capture anti-CD146 antibody to form sensing layer by the interaction between Fc part of antibody and protein G. Firstly, 10μl of a mixture solution which is prepared with NHS and EDC at the concentration of 0.05mol/ml and 0.2mol/ml in deionized water is added to the micro-fluidic reactor system and passed through the surface at a flow rate of 5μl/min. With NHS and EDC, carboxyl groups on the substrate could react with the amino groups of the protein. Then, 10μl of Protein G at 0.25mg/ml is adsorbed on the substrate at a flow rate of 1 μl/min. After that, 20μl of anti-CD146 antibody diluted 200 times in PBST buffer as ligands is immobilized specifically to protein G at a flow rate of 1μl/min. Finally, the silicon surface is blocked by blocking buffer in order to lessen the impact caused by non-specific adsorption of human serum. After these four steps, the sensing surface for CD146 detection is ready in use. When the detection begins, 20μl of CD146 standard sample or human serum dilution solution is delivered into individual channel to CD146 sensing surface by the micro-fluidic system at a flow rate of 1 μl/min. After being rinsed with plenty of PBST and dried under nitrogen, the microarray is sampled and recorded as images in grayscale by the imaging ellipsometry reader.
Calibration curve for CD146 quantitative detection
Calibration curve is used to achieve the goal of quantitative detection. The CD146 standard serum sample is diluted to 3, 9, 27, 81 and 243 times with PBST in term of the equal proportion dilution rule, that is to say, the concentration of CD146 is from 81ng/ml to 1ng/ml. The calibration curve is established three times for verifying the results, and each concentration is measured twice as well. Strictly following the procedures above, results in grayscale of 5 diluted samples and the original sample are obtained and then plotted according to CD146 concentration to establish calibration curve.
Quantitative detection of human serum samples
18 human serum samples are detected by the same procedure to setup calibration curve. In order to ensure CD146 concentration within the range of calibration curve, all serum samples are diluted to 5 times before detection. Each serum is measured twice, and then the results are calculated by the calibration. The BIE results are compared with those from ELISA assay by the correlation analysis.
MATERIALS AND METHODS
Constitution of CD146 sensing layer
Because Protein G could bind the Fc part of antibody strongly, it is used to immobilize anti-CD146 antibody and then form CD146 sensing surface. By this means, anti-CD146 antibody in complex sample could be purified; meanwhile, oriented immobilization of anti-CD146 antibody is realized on silicon surface. The result for CD146 sensing surface constitution is showed in Figure1. Protein G is covalently adsorbed in all the 6 units of the microarray, and then they are reacted with anti-CD146 antibody in row b and row c units. After that, blocking buffer is added into row c units. Compared with Protein G, the grayscale value of units in the microarray where anti-CD146 antibody is reacted with Protein G increases remarkably from 78.0 to 92.8. It indicates that anti-CD146 antibody is captured by Protein G and fabricate sensing layer. 
Detection of CD146
To detect CD146, blank control and negative control are set to ensure detection accuracy and avoid false positive. Results are demonstrated in Figure 2A and the corresponding numerical values are listed in Figure  2B . Protein G is immobilized in all the 8 units. Then BSA is reacted in row a and row b, while CD146 is added in row c and row d. After blocked by blocking buffer, CD 146 standard sample is delivered in row b and row d, while PBST is added in row a and row c. In that case, row a and row b is blank control, whereas, row c is negative control. In the blank control units, compared to row a, grayscale value in row b increases from 89.3 to 90.8 after reacted with standard sample. It is suggested that the non-specific adsorption and other errors may cause an increase of 1.5 grayscale value. In other word, grayscale value increasing beyond 1.5 can be contributed to the specific binding between CD146 and its corresponding antibody. The average grayscale value of sample units is 103.6 while the negative control is 93.2. As a result, it can be concluded that CD146 is captured by anti-CD146 antibody on biosensor surface because the increase is 11.4 which are far more than 1.5. 
Calibration for CD146 quantitative detection
CD146 standard sample is diluted at geometric proportion to 5 grads that are 81ng/ml, 27ng/ml, 9ng/ml, 3ng/ml and 1ng/ml, respectively, and then reacted with anti-CD146 antibody sensing surface. The calibration curve is showed in Figure 3 . It indicates that with the decay of concentration of CD146, the relevant grayscale value declines, and the variable regulation between them appears a logarithm formulation. After a logarithmic transformation of CD146 concentration, the result in grayscale is plotted toward logarithm of CD146 concentration. The 6 points are almost in line of which the slope and R 2 (the percentage of total variation in the response that can be explained by factors in regression analysis and the higher R2, the better fit.) are 3.3 and 0.987, respectively. When CD146 concentration is at 1ng/ml and 3ng/ml, respectively, the biosensor signal shows a significant difference. It can be confirmed that the sensitivity of the biosensor for CD146 detection reaches the order of ng/ml. The calibration curve appears a logarithm relationship between the biosensor signal y in grayscale and CD146 concentration x in ng/ml: y = 3.3ln(x) + 91.3. It can be foreseen that the concentration of CD146 between 1ng/ml and 243ng/ml can be quantitatively detected by BIE with the calibration curve above. 
Serum sample detection
18 human serum samples are tested as a trial to clinical detection. The results of 18 sera are collected and dealt in the same way, and then the results in grayscale can be obtained through home-made software. ELISA, as a conventional biological manner, is set for the comparison. Both tests are performed without knowledge of the clinical status of the patients or the results of another. The difference between ELISA and the biosensor is evaluated with correlation analysis. The index is 0.923 which demonstrates that the result of the two test manner has significant statistic relevance at the level of 0.01. 
Conclusions
Protein G is applied to bind anti-CD146 antibody and form CD146 sensing layer. It combines the process of purification of antibody in ascites sample and high oriented immobilization together.
CD146 is chosen to be a model to develop BIE as protocol tumor markers detection. CD146 is recognized and captured on its sensing surface and the detection sensitivity is beyond the order of ng/ml grade. The results of serum sample are highly in agreement to ELISA which is a traditional biological method widely used in many aspects of protein-protein interaction research and clinical diagnosis.
